Michael R. Bristow
2016
In 2016, Michael R. Bristow earned a total compensation of $572.3K as President and Chief Executive Officer at ARCA biopharma, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $92,300 |
|---|---|
| Option Awards | $169,693 |
| Salary | $294,036 |
| Other | $16,227 |
| Total | $572,256 |
Bristow received $294K in salary, accounting for 51% of the total pay in 2016.
Bristow also received $92.3K in non-equity incentive plan, $169.7K in option awards and $16.2K in other compensation.
Rankings
In 2016, Michael R. Bristow's compensation ranked 10,695th out of 14,075 executives tracked by ExecPay. In other words, Bristow earned more than 24.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,695 out of 14,075 | 24th |
Division Manufacturing | 4,156 out of 5,489 | 24th |
Major group Chemicals And Allied Products | 1,474 out of 1,895 | 22nd |
Industry group Drugs | 1,184 out of 1,538 | 23rd |
Industry In Vitro and In Vivo Diagnostic Substances | 45 out of 65 | 31st |
Source: SEC filing on April 21, 2017.
Bristow's colleagues
We found two more compensation records of executives who worked with Michael R. Bristow at ARCA biopharma in 2016.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019